Cardiovascular Business

Cardiovascular Business Cardiovascular Business is a news, business and technology source for cardiovascular medicine.

We focus on the business and economics behind the foremost clinical, interventional, surgical and information technologies.

The interventional device from Edwards Lifesciences is at the center of two new studies published in EuroIntervention.
08/04/2025

The interventional device from Edwards Lifesciences is at the center of two new studies published in EuroIntervention.

The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. ...
08/04/2025

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker.

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker.

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.
08/04/2025

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

Cardiologist compensation in the United States is experiencing slow, but steady growth, according to a new analysis from...
08/01/2025

Cardiologist compensation in the United States is experiencing slow, but steady growth, according to a new analysis from Doximity

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties?

Tirzepatide met the primary endpoint of non-inferiority vs. dulaglutide, with 8% lower MACE rate and delivering greater ...
08/01/2025

Tirzepatide met the primary endpoint of non-inferiority vs. dulaglutide, with 8% lower MACE rate and delivering greater reductions in A1C and weight.

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients.
07/31/2025

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients.

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients.

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new res...
07/31/2025

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new research published in the Journal of the American Heart Association. It did not improve survival.

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new research published in the Journal of the American Heart Association. It does not, however, improve survival.

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society has ...
07/31/2025

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society has shared a detailed analysis of the situation with its members.

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society shared a detailed analysis of the situation.

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. ...
07/30/2025

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.

CARMAT is working to overcome a lack of funding that forced it to suspend new device implants through the end of August....
07/30/2025

CARMAT is working to overcome a lack of funding that forced it to suspend new device implants through the end of August. But even with its future in limbo, the company remains focused on moving forward.

Carmat is working to overcome financial struggles that forced it to suspend new device implants through the end of August. Even with its future in limbo, the company remains focused on moving forward.

Video - Former ACC president Kim Allan Williams, MD, University of Louisville School of Medicine, discusses how his cent...
07/30/2025

Video - Former ACC president Kim Allan Williams, MD, University of Louisville School of Medicine, discusses how his center has made a difference with a heart screening outreach program in low-income neighborhoods.

Former ACC president Kim Allan Williams Sr., MD, shares his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said.

Researchers explored data from thousands of U.S. veterans with coronary artery disease, sharing their findings in Circul...
07/29/2025

Researchers explored data from thousands of U.S. veterans with coronary artery disease, sharing their findings in Circulation.

Researchers explored data from thousands of U.S. veterans with coronary artery disease, sharing their findings in Circulation.

Address

Providence, RI

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when Cardiovascular Business posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cardiovascular Business:

Share